CD34 and acute myeloid leukemia: We provide strong evidence that all tested AML samples, regardless of whether they have recurrent cytogenetic abnormalities or not, expressed higher levels of nuclear HSF1 proteins than normal BM cells, and the expression of HSF1 is not limited to CD34+ blasts.